ALVO vs. GNCAQ, VECT, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, and AONC
Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Genocea Biosciences (GNCAQ), VectivBio (VECT), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), and American Oncology Network (AONC). These companies are all part of the "medical" sector.
Genocea Biosciences (NASDAQ:GNCAQ) and Alvotech (NYSE:ALVO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, community ranking, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.
Alvotech has a consensus price target of $12.67, suggesting a potential downside of 5.47%.
In the previous week, Alvotech had 5 more articles in the media than Genocea Biosciences. MarketBeat recorded 6 mentions for Alvotech and 1 mentions for Genocea Biosciences. Genocea Biosciences' average media sentiment score of 0.47 beat Alvotech's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.
Alvotech received 4 more outperform votes than Genocea Biosciences when rated by MarketBeat users.
Genocea Biosciences has a beta of 2.31, meaning that its stock price is 131% more volatile than the S&P 500. Comparatively, Alvotech has a beta of 0.07, meaning that its stock price is 93% less volatile than the S&P 500.
Genocea Biosciences has higher earnings, but lower revenue than Alvotech.
Genocea Biosciences has a net margin of 0.00% compared to Genocea Biosciences' net margin of -967.97%.
Summary
Alvotech beats Genocea Biosciences on 5 of the 9 factors compared between the two stocks.
Get Alvotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alvotech Competitors List
Related Companies and Tools
